{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:47:43Z","timestamp":1787312863404,"version":"build-2736575974"},"reference-count":79,"publisher":"American Veterinary Medical Association (AVMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["javma"],"published-print":{"date-parts":[[2014,2,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:bold>Objective<\/jats:bold>\n                    \u2014To determine prevalence, reason for evaluation, treatment, and outcome for dogs and cats with presumed solitary ocular lymphoma (PSOL).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Design<\/jats:bold>\n                    \u2014Retrospective case series.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Animals<\/jats:bold>\n                    \u20147 dogs and 2 cats with PSOL.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Procedures<\/jats:bold>\n                    \u2014Medical records were reviewed. Progression-free survival time (PFST) and overall survival time (OST) were determined.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results<\/jats:bold>\n                    \u2014Animals with intraocular (4 dogs and 1 cat) or conjunctival (3 dogs and 1 cat) lymphoma represented 0.1% and 0.08% of patients with lymphoma evaluated at the hospital during the study period, respectively. Animals with intraocular lymphoma represented 0.19% of all patients with uveitis; animals with conjunctival lymphoma represented 0.16% of all patients with conjunctivitis. Tumors included B-cell (2 intraocular and 1 conjunctival), non\u2013B-cell, non\u2013T-cell (1 intraocular), and T-cell (3 conjunctival) neoplasms; immunophenotype of 2 uveal lymphomas was not determined. Treatments included enucleation (4 intraocular) and chemotherapy (3 intraocular and 2 conjunctival). All dogs with intraocular lymphoma developed neurologic signs. Lymph node metastasis was detected in 2 patients with conjunctival lymphoma. Median PFST and OST were 178 days for all animals with PSOL, dogs with PSOL, and animals with intraocular lymphoma. Median PFST and OST for animals with conjunctival lymphoma were 221 and 549 days, respectively.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusions and Clinical Relevance<\/jats:bold>\n                    \u2014Results indicated PSOL was uncommon, but should be considered a differential diagnosis for animals with uveitis or conjunctivitis. Performance of MRI and cytologic analysis of CSF and regional lymph node aspirate samples may be beneficial for such patients. Prognosis seemed to be better for animals with conjunctival lymphoma than it was for those with intraocular lymphoma.\n                  <\/jats:p>","DOI":"10.2460\/javma.244.4.460","type":"journal-article","created":{"date-parts":[[2014,1,30]],"date-time":"2014-01-30T15:26:46Z","timestamp":1391095606000},"page":"460-470","source":"Crossref","is-referenced-by-count":37,"title":["Presumed solitary intraocular or conjunctival lymphoma in dogs and cats: 9 cases (1985\u20132013)"],"prefix":"10.2460","volume":"244","author":[{"given":"K. Tomo","family":"Wiggans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine A.","family":"Skorupski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"Reilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara A.","family":"Frazier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard R.","family":"Dubielzig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Maggs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1272","reference":[{"key":"ref1","series-title":"Withrow and MacEwen's small animal clinical oncology","first-page":"699","article-title":"Hematopoietic tumors","author":"Vail","year":"2007"},{"key":"ref2","series-title":"Vet Comp Ophthalmol","first-page":"127","article-title":"Prevalence of ocular involvement in dogs with multicentric lymphoma: prospective evaluation of 94 cases","volume":"4","author":"Krohne","year":"1994"},{"key":"ref3","series-title":"Vet Pathol","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1177\/0300985810363902","article-title":"A morphological study of 608 cases of canine malignant lymphoma in France with a focus on comparative similarities between canine and human lymphoma morphology","volume":"47","author":"Ponce","year":"2010"},{"key":"ref4","series-title":"Vet Comp Oncol","article-title":"Canine indolent and aggressive lymphoma: clinical spectrum with histologic correlation","author":"Aresu"},{"key":"ref5","series-title":"J Am Vet Med Assoc","first-page":"837","article-title":"Lymphocytic lymphosarcoma of the canine eye","volume":"147","author":"Whitford","year":"1965"},{"key":"ref6","series-title":"Can J Ophthalmol","first-page":"185","article-title":"Combined local chemotherapy for a spontaneously occurring intraocular tumour in a cat","volume":"18","author":"Rootman","year":"1983"},{"key":"ref7","series-title":"J Am Vet Med Assoc","doi-asserted-by":"publisher","first-page":"625","DOI":"10.2460\/javma.238.5.625","article-title":"Diagnosis of intraocular lymphosarcoma in a dog by use of a polymerase chain reaction assay for antigen receptor rearrangement","volume":"238","author":"Pate","year":"2011"},{"key":"ref8","series-title":"Vet Ophthalmol","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/j.1463-5224.2012.01025.x","article-title":"A case of oculo-cerebral B-cell lymphoma in a cat","volume":"16","author":"Giordano","year":"2013"},{"key":"ref9","series-title":"J Small Anim Pract","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/j.1748-5827.2000.tb03209.x","article-title":"Epitheliotropic lymphoma (mycosis fungoides) presenting as blepharoconjunctivitis in an Irish Setter","volume":"41","author":"Donaldson","year":"2000"},{"key":"ref10","series-title":"Vet Ophthalmol","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/j.1463-5224.2004.04035.x","article-title":"B-cell conjunctival lymphoma in a cat","volume":"7","author":"Radi","year":"2004"},{"key":"ref11","series-title":"Vet Ophthalmol","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/j.1463-5224.2005.04053.x","article-title":"Unicentric extranodal lymphoma of the upper eyelid conjunctiva in a dog","volume":"8","author":"Vascellari","year":"2005"},{"key":"ref12","series-title":"Vet Ophthalmol","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/j.1463-5224.2006.00451.x","article-title":"Extranodal conjunctival Hodgkin's-like lymphoma in a cat","volume":"9","author":"Holt","year":"2006"},{"key":"ref13","series-title":"Vet Ophthalmol","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/j.1463-5224.2010.00843.x","article-title":"Mucosa-associated lymphoid tissue lymphoma of the third eyelid conjunctiva in a dog","volume":"14","author":"Hong","year":"2011"},{"issue":"suppl 1","key":"ref14","series-title":"Vet Ophthalmol","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1111\/j.1463-5224.2012.01027.x","article-title":"Supposed primary conjunctival lymphoma in a dog","volume":"16","author":"Olbertz","year":"2013"},{"key":"ref15","series-title":"Hematol Oncol","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/hon.741","article-title":"Ophthalmologic and intraocular non-Hodgkin's lymphoma: a large single centre study of initial characteristics, natural history, and prognostic factors","volume":"22","author":"Meunier","year":"2004"},{"key":"ref16","series-title":"J Natl Cancer Inst","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1093\/jnci\/djj248","article-title":"Rapidly increasing incidence of ocular non-hodgkin lymphoma","volume":"98","author":"Moslehi","year":"2006"},{"key":"ref17","series-title":"Semin Ophthalmol","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1080\/08820530500350498","article-title":"Primary intraocular lymphoma: a review","volume":"21","author":"Choi","year":"2006"},{"key":"ref18","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s11060-011-0618-1","article-title":"Primary intraocular lymphoma: a review","volume":"105","author":"Vosganian","year":"2011"},{"key":"ref19","series-title":"J Vet Intern Med","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/j.1939-1676.2008.0057.x","article-title":"Combination chemotherapy in feline lymphoma: treatment outcome, tolerability, and duration in 23 cats","volume":"22","author":"Simon","year":"2008"},{"key":"ref20","series-title":"J Small Anim Pract","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1111\/j.1748-5827.2009.00813.x","article-title":"Feline extranodal lymphoma: response to chemotherapy and survival in 110 cats","volume":"50","author":"Taylor","year":"2009"},{"key":"ref21","series-title":"J Am Vet Med Assoc","first-page":"696","article-title":"Treatment and prognostic factors in lymphoma in cats: 103 cases (1977\u20131981)","volume":"194","author":"Mooney","year":"1989"},{"key":"ref22","series-title":"J Am Vet Med Assoc","first-page":"1722","article-title":"Prognostic factors for treatment of malignant lymphoma in dogs","volume":"205","author":"Teske","year":"1994"},{"key":"ref23","series-title":"J Am Anim Hosp Assoc","doi-asserted-by":"publisher","first-page":"404","DOI":"10.5326\/15473317-36-5-404","article-title":"Factors influencing first remission and survival in 145 dogs with lymphoma: a retrospective study","volume":"36","author":"Baskin","year":"2000"},{"key":"ref24","series-title":"J Vet Med A Physiol Pathol Clin Med","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1046\/j.1439-0442.2002.00458.x","article-title":"A retrospective study of the incidence and prognostic factors of multicentric lymphoma in dogs (1998\u20132000)","volume":"49","author":"Jagielski","year":"2002"},{"key":"ref25","series-title":"J Am Vet Med Assoc","doi-asserted-by":"publisher","first-page":"480","DOI":"10.2460\/javma.238.4.480","article-title":"Predictors of long-term survival in dogs with high-grade multicentric lymphoma","volume":"238","author":"Marconato","year":"2011"},{"key":"ref26","series-title":"J Vet Intern Med","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/j.1939-1676.1998.tb02134.x","article-title":"Feline lymphoma (145 cases): proliferation indices, cluster of differentiation 3 immunoreactivity, and their association with prognosis in 90 cats","volume":"12","author":"Vail","year":"1998"},{"key":"ref27","series-title":"TNM classification of tumours in domestic animals","author":"Owen","year":"1980"},{"key":"ref28","series-title":"Dev Comp Immunol","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/S0145-305X(98)00022-6","article-title":"Comparative anatomy of mammalian conjunctival lymphoid tissue: a putative mucosal immune site","volume":"22","author":"Chodosh","year":"1998"},{"key":"ref29","series-title":"Graefes Arch Clin Exp Ophthalmol","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1007\/s00417-002-0429-3","article-title":"Morphological evidence of M cells in healthy canine conjunctiva-associated lymphoid tissue","volume":"240","author":"Giuliano","year":"2002"},{"key":"ref30","series-title":"Physiol Rev","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1152\/physrev.1975.55.3.383","article-title":"Blood circulation and fluid dynamics in the eye","volume":"55","author":"Bill","year":"1975"},{"key":"ref31","series-title":"Exp Eye Res","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.exer.2011.07.006","article-title":"A model to measure lymphatic drainage from the eye","volume":"93","author":"Kim","year":"2011"},{"key":"ref32","series-title":"Exp Eye Res","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.exer.2009.08.010","article-title":"Identification of lymphatics in the ciliary body of the human eye: a novel \u201cuveolymphatic\u201d outflow pathway","volume":"89","author":"Y\u00fccel","year":"2009"},{"key":"ref33","series-title":"Invest Ophthalmol Vis Sci","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1167\/iovs.08-3307","article-title":"Expression of podoplanin and other lymphatic markers in the human anterior eye segment","volume":"51","author":"Birke","year":"2010"},{"key":"ref34","series-title":"Vet Pathol","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1354\/vp.39-1-74","article-title":"Localized and disseminated histiocytic sarcoma of dendritic cell origin in dogs","volume":"39","author":"Affolter","year":"2002"},{"key":"ref35","series-title":"Vet Pathol","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1354\/vp.40-1-32","article-title":"Diagnosis of canine lymphoid neoplasia using clonal rearrangements of antigen receptor genes","volume":"40","author":"Burnett","year":"2003"},{"key":"ref36","series-title":"Vet Ophthalmol","article-title":"Diagnostic utility of aqueocentesis and aqueous humor analysis in dogs and cats with anterior uveitis","author":"Wiggans"},{"key":"ref37","series-title":"Vet Ophthalmol","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1046\/j.1463-5224.2002.00217.x","article-title":"Causes of uveitis in dogs: 102 cases (1989\u20132000)","volume":"5","author":"Massa","year":"2002"},{"key":"ref38","series-title":"Cornell Vet","first-page":"492","article-title":"Ocular changes in malignant lymphoma of dogs","volume":"52","author":"Cello","year":"1962"},{"key":"ref39","series-title":"Vet J","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.tvjl.2008.05.027","article-title":"A prospective study of the association of anemia and thrombocytopenia with ocular lesions in dogs","volume":"182","author":"Shelah-Goraly","year":"2009"},{"key":"ref40","series-title":"J Am Vet Med Assoc","first-page":"564","article-title":"Evaluation of some prognostic factors for advanced multicentric lymphosarcoma in the dog: 147 cases (1978\u20131981)","volume":"190","author":"MacEwen","year":"1987"},{"key":"ref41","series-title":"J Vet Intern Med","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1111\/j.1939-1676.1996.tb02083.x","article-title":"A comparison of doxorubicin and COP for maintenance of remission in cats with lymphoma","volume":"10","author":"Moore","year":"1996"},{"key":"ref42","series-title":"J Small Anim Pract","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/j.1748-5827.2001.tb02485.x","article-title":"Prognostic variables in canine multicentric lymphosarcoma","volume":"42","author":"Dobson","year":"2001"},{"key":"ref43","series-title":"J Am Vet Med Assoc","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.2460\/javma.2005.227.1118","article-title":"Response rates and survival times for cats with lymphoma treated with the University of Wisconsin-Madison chemotherapy protocol: 38 cases (1996\u2013 2003)","volume":"227","author":"Milner","year":"2005"},{"key":"ref44","series-title":"J Vet Intern Med","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1111\/j.1939-1676.2007.tb03062.x","article-title":"Stage migration in dogs with lymphoma","volume":"21","author":"Flory","year":"2007"},{"key":"ref45","series-title":"Front Immunol","first-page":"296","article-title":"The privileged immunity of immune privileged organs: the case of the eye","volume":"3","author":"Benhar","year":"2012"},{"key":"ref46","series-title":"Hematol Oncol Clin North Am","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.hoc.2005.05.011","article-title":"Diagnosis and management of primary intraocular lymphoma","volume":"19","author":"Levy-Clarke","year":"2005"},{"key":"ref47","series-title":"Cancer","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1002\/1097-0142(19860401)57:7<1273::AID-CNCR2820570702>3.0.CO;2-C","article-title":"Treatment of intraocular lymphoma with high-dose Ara-C","volume":"57","author":"Baumann","year":"1986"},{"key":"ref48","series-title":"Cancer","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1002\/1097-0142(19890515)63:10<1918::AID-CNCR2820631008>3.0.CO;2-D","article-title":"Chemotherapy in the management of intraocular lymphoma","volume":"63","author":"Strauchen","year":"1989"},{"key":"ref49","series-title":"Clin Cancer Res","first-page":"711","article-title":"High-dose methotrexate for intraocular lymphoma","volume":"9","author":"Batchelor","year":"2003"},{"key":"ref50","series-title":"J Clin Oncol","doi-asserted-by":"publisher","first-page":"3000","DOI":"10.1200\/JCO.1998.16.9.3000","article-title":"Phase II trial of chemotherapy alone for primary CNS and intraocular lymphoma","volume":"16","author":"Sandor","year":"1998"},{"key":"ref51","series-title":"Ophthalmology","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/S0161-6420(03)00268-9","article-title":"Intrathecal chemotherapy for recurrent central nervous system intraocular lymphoma","volume":"110","author":"Mason","year":"2003"},{"key":"ref52","series-title":"Arch Ophthalmol","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1001\/archopht.1997.01100160322009","article-title":"Intravitreal methotrexate as an adjunctive treatment of intraocular lymphoma","volume":"115","author":"Fishburne","year":"1997"},{"key":"ref53","series-title":"Br J Ophthalmol","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1136\/bjo.83.4.448","article-title":"Intravitreal chemotherapy for the treatment of recurrent intraocular lymphoma","volume":"83","author":"de Smet","year":"1999"},{"key":"ref54","series-title":"Ophthalmology","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1016\/S0161-6420(02)01125-9","article-title":"Role of intravitreal methotrexate in the management of primary central nervous system lymphoma with ocular involvement","volume":"109","author":"Smith","year":"2002"},{"key":"ref55","series-title":"Can J Ophthalmol","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/S0008-4182(03)80115-1","article-title":"Intravitreal methotrexate injections for intraocular involvement in primary central nervous system lymphoma","volume":"38","author":"Tourville","year":"2003"},{"key":"ref56","series-title":"Jpn J Ophthalmol","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s10384-008-0519-9","article-title":"Treatment of primary intraocular lymphoma with intravitreal methotrexate","volume":"52","author":"Sou","year":"2008"},{"key":"ref57","series-title":"Ann Oncol","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1093\/annonc\/mdf080","article-title":"Relevance of intraocular involvement in the management of primary central nervous system lymphomas","volume":"13","author":"Ferreri","year":"2002"},{"key":"ref58","series-title":"Br J Haematol","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/j.1365-2141.2010.08321.x","article-title":"Treatment of isolated primary intraocular lymphoma with high-dose methotrexate-based chemotherapy and binocular radiation therapy: a single-institution experience","volume":"151","author":"Stefanovic","year":"2010"},{"key":"ref59","series-title":"Ann Hematol","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1007\/s00277-010-1139-2","article-title":"Combined therapy associating systemic platinum-based chemotherapy and local radiotherapy into the treatment of primary intraocular lymphoma","volume":"90","author":"Tempescul","year":"2011"},{"key":"ref60","series-title":"Blood","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1182\/blood-2008-12-195453","article-title":"Extranodal marginal zone lymphoma of the ocular adnexa","volume":"114","author":"Stefanovic","year":"2009"},{"key":"ref61","series-title":"Ophthalmology","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0161-6420(85)34073-3","article-title":"Conjunctival involvement with mycosis fungoides in a patient receiving PUVA therapy","volume":"92","author":"O'Day","year":"1985"},{"key":"ref62","series-title":"Arch Ophthalmol","first-page":"508","article-title":"Clinicopathologic reports, case reports, and small case series: rapidly progressive T-cell lymphoma of the conjunctiva","volume":"120","author":"Shields","year":"2002"},{"key":"ref63","series-title":"Ophthalmology","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.ophtha.2005.10.042","article-title":"Conjunctival T-cell lymphoma: a clinicopathologic case report","volume":"113","author":"Al-Muammar","year":"2006"},{"key":"ref64","series-title":"Ophthalmology","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/S0161-6420(99)90163-X","article-title":"Conjunctival lymphoma masquerading as chronic conjunctivitis","volume":"106","author":"Akpek","year":"1999"},{"key":"ref65","series-title":"Cornea","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1097\/00003226-200105000-00019","article-title":"Bilateral conjunctival mucosa-associated lymphoid tissue lymphoma misdiagnosed as allergic conjunctivitis","volume":"20","author":"Lee","year":"2001"},{"key":"ref66","series-title":"Onkologie","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1159\/000313853","article-title":"Bilateral conjunctival MALT lymphoma mimicking chronic conjunctivitis","volume":"33","author":"Seker","year":"2010"},{"key":"ref67","series-title":"Am J Ophthalmol","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.ajo.2008.03.013","article-title":"Ocular adnexal lymphoid tumors: progress in need of clarification","volume":"145","author":"Jakobiec","year":"2008"},{"key":"ref68","series-title":"Ophthalmology","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.ophtha.2006.01.057","article-title":"Oral chlorambucil for extranodal, marginal zone, B-cell lymphoma of mucosa-associated lymphoid tissue of the orbit","volume":"113","author":"Ben Simon","year":"2006"},{"key":"ref69","series-title":"Korean J Ophthalmol","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3341\/kjo.2006.20.1.7","article-title":"The clinical characteristics and treatment results of ocular adnexal lymphoma","volume":"20","author":"Woo","year":"2006"},{"key":"ref70","series-title":"Int J Radiat Oncol Biol Phys","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/j.ijrobp.2011.04.052","article-title":"Long-term outcome and patterns of failure in primary ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiotherapy","volume":"82","author":"Hashimoto","year":"2012"},{"key":"ref71","series-title":"Int J Radiat Oncol Biol Phys","doi-asserted-by":"publisher","first-page":"e659","DOI":"10.1016\/j.ijrobp.2011.03.050","article-title":"Localized orbital mucosa-associated lymphoma tissue lymphoma managed with primary radiation therapy: efficacy and toxicity","volume":"81","author":"Goda","year":"2011"},{"key":"ref72","series-title":"Int J Radiat Oncol Biol Phys","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1016\/j.ijrobp.2010.07.1992","article-title":"Treatment effects and sequelae of radiation therapy for orbital mucosa-associated lymphoid tissue lymphoma","volume":"81","author":"Hata","year":"2011"},{"key":"ref73","series-title":"Eur J Haematol","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/j.1600-0609.2004.00299.x","article-title":"Anti-CD20 monoclonal antibody therapy in relapsed MALT lymphoma of the conjunctiva","volume":"73","author":"N\u00fcckel","year":"2004"},{"key":"ref74","series-title":"Ophthalmology","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ophtha.2010.04.036","article-title":"Intralesional rituximab: a new therapeutic approach for patients with conjunctival lymphomas","volume":"118","author":"Ferreri","year":"2011"},{"key":"ref75","series-title":"Am J Ophthalmol","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.ajo.2005.03.060","article-title":"Periocular mucosa-associated lymphoid\/low grade lymphomas: treatment with antibiotics","volume":"140","author":"Abramson","year":"2005"},{"key":"ref76","series-title":"J Vet Intern Med","first-page":"1389","article-title":"Response of canine cutaneous epitheliotropic lymphoma to lomustine (CCNU): a retrospective study of 46 cases (1999\u20132004)","volume":"20","author":"Risbon","year":"2006"},{"key":"ref77","series-title":"Vet Dermatol","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/j.1365-3164.2009.00793.x","article-title":"Canine cutaneous epitheliotropic T-cell lymphoma: a review of 30 cases","volume":"21","author":"Fontaine","year":"2010"},{"key":"ref78","series-title":"J Vet Intern Med","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/j.1939-1676.2006.tb02833.x","article-title":"CCNU in the treatment of canine epitheliotropic lymphoma","volume":"20","author":"Williams","year":"2006"},{"key":"ref79","series-title":"Vet Comp Oncol","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1476-5829.2008.00176.x","article-title":"Canine cutaneous epitheliotropic T-cell lymphoma: a review","volume":"7","author":"Fontaine","year":"2009"}],"container-title":["Journal of the American Veterinary Medical Association"],"original-title":[],"link":[{"URL":"https:\/\/avmajournals.avma.org\/view\/journals\/javma\/244\/4\/javma.244.4.460.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/avmajournals.avma.org\/downloadpdf\/journals\/javma\/244\/4\/javma.244.4.460.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/avmajournals.avma.org\/downloadpdf\/journals\/javma\/244\/4\/javma.244.4.460.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T06:43:54Z","timestamp":1741329834000},"score":1,"resource":{"primary":{"URL":"https:\/\/avmajournals.avma.org\/view\/journals\/javma\/244\/4\/javma.244.4.460.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,15]]},"references-count":79,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.2460\/javma.244.4.460","relation":{},"ISSN":["0003-1488"],"issn-type":[{"value":"0003-1488","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2,15]]}}}